Johnson
The company said 60,000 volunteers participated in the trial in the United States, Argentina, Brazil, Chile, Colombia, Mexico, Peru and South Africa.
Several other coronavirus vaccines in the United States and other countries are already in the last phase of testing, adding those that evolved through Moderna Inc. Pfizer Inc.
Many vaccine experts wonder whether the U. S. Food and Drug Administration will be able to do so. But it’s not the first time It will take shortcuts to final approval from President Donald Trump, who has presented a shorter verification schedule than experts des fit to fully verify candidates.
President Trump, who predicted a vaccine would be obtained until the November 3 presidential election, rejected Wednesday to expedite approval of a vaccine, tweeting that the FDA “must act fast!”
However, the director of the US National Institutes of Health, however, has not been able to do so. Dr. Francis Collins told reporters this week that “we have to do everything we can to sacrifice protection or efficiency. “
The Washington Post reported Wednesday that the FDA, in an effort to publicize transparency, would reveal the main points of a stricter vaccine for emergency approval, reducing the chances of a vaccine being approved before Election Day.
Even if the FDA allowed emergency use of a vaccine until the end of the year, limited vaccine materials would first be given to vulnerable equipment, such as physical care workers.
Unlike experimental coronavirus vaccines being tested in the United States, which require two injections, J